Q3 results highlighted continued growth in Vyvgart sales, while its acquisition of Forte Biosciences broadened the company's late-stage pipeline ahead of a potentially important phase 3 readout for ...
RNAi specialist Alnylam Pharmaceuticals will advance the Huntington’s disease drug brezosiran into a placebo-controlled study ...
Learn more Amgen (AMGN) has an average rating of hold and mean price target of $403.61, according to analysts polled by FactSet.
NYT Mini Crossword for Friday, October 23, 2026, brings ten clues on trains, measurement, online chats, fashion, basketball, ...
The 30-year-old director of Primetime and You Can See Everything gets candid about the odd trio that defined the last few ...
Fintel reports that on 22 October 2026, Oppenheimer initiated coverage of Kratos Defense & Security Solutions (XTRA:WF5A) with a Outperform recommendation. Kratos Defense & Security Solutions, Inc., ...
As different as millennials and Gen Z are, that isn't to say that we can't enjoy some cinema of the past. The '70s were a ...
Zdobył siedem Oscarów, ale o jego sile najlepiej świadczy nie lista nagród, lecz niepokój, który pozostaje po seansie. W ...
The news is fundamentally positive: revenue +138% to $1.24B, EPS 94c vs 69c expected, and full-year revenue guidance raised ...
Other publishers think of GTA 6 as a catastrophe that might just destroy anything that comes closer to it. But one game that ...
Fintel reports that on 16 October 2026, Oppenheimer downgraded their outlook for Equifax (DB:EFX) from Outperform to Perform. Prior to this rating action, on 12 January 2026, Oppenheimer had ...
Toshkent shahri hokimligi va AQShning Oppenheimer & Co. banki shahar loyihalarini moliyalashtirish uchun munitsipal obligatsiyalar chiqarish imkoniyatini muhokama qildi. Tomonlar hamkorlik to‘g‘risida ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results